Total Payments
$2,301
2024 Payments
$544.93
Companies
20
Transactions
111
Medicare Patients
887
Medicare Billing
$110,450
Payment Breakdown by Category
Food & Beverage$2,242 (97.5%)
Education$58.61 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,242 | 109 | 97.5% |
| Education | $58.61 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $615.20 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $417.40 | 22 | $0 (2024) |
| Micro-tech Endoscopy USA, Inc. | $214.00 | 1 | $0 (2018) |
| Celgene Corporation | $188.61 | 16 | $0 (2023) |
| Novo Nordisk Inc | $170.02 | 10 | $0 (2023) |
| Celltrion USA Inc. | $114.16 | 4 | $0 (2024) |
| PFIZER INC. | $107.97 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $86.60 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $73.23 | 4 | $0 (2022) |
| Lilly USA, LLC | $56.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.93 | 26 | ABBVIE INC. ($155.07) |
| 2023 | $508.33 | 32 | AbbVie Inc. ($155.57) |
| 2022 | $626.87 | 31 | ABBVIE INC. ($304.56) |
| 2021 | $296.34 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($175.30) |
| 2020 | $41.30 | 2 | Gilead Sciences, Inc. ($24.13) |
| 2019 | $50.47 | 2 | Boston Scientific Corporation ($50.47) |
| 2018 | $214.00 | 1 | Micro-tech Endoscopy USA, Inc. ($214.00) |
| 2017 | $18.51 | 1 | Valeant Pharmaceuticals North America LLC ($18.51) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.04 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Immunology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/04/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $28.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Gastroenterology | ||||||
| 05/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $30.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 159 | 241 | $173,280 | $20,719 |
| 2022 | 10 | 350 | 470 | $403,449 | $44,948 |
| 2021 | 12 | 361 | 446 | $327,805 | $42,861 |
| 2020 | 1 | 17 | 29 | $8,410 | $1,923 |
Total Patients
887
Total Services
1,186
Medicare Billing
$110,450
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 122 | $35,380 | $8,741 | 24.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $19,440 | $4,172 | 21.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $42,400 | $1,685 | 4.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $51,200 | $1,626 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 18 | $9,540 | $1,600 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $9,240 | $1,523 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $6,080 | $1,372 | 22.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 129 | $50,310 | $11,917 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 72 | $38,160 | $7,452 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $29,700 | $6,475 | 21.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 43 | 47 | $99,812 | $4,279 | 4.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 66 | $19,140 | $4,212 | 22.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $95,017 | $3,013 | 3.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 33 | 33 | $13,530 | $2,875 | 21.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 12 | 12 | $46,920 | $2,334 | 5.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $10,400 | $2,323 | 22.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 23 | $460.00 | $68.19 | 14.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 82 | $31,980 | $7,743 | 24.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 64 | 94 | $27,260 | $6,154 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 50 | $24,600 | $5,516 | 22.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 34 | 35 | $18,900 | $4,254 | 22.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 43 | 45 | $18,450 | $4,145 | 22.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 40 | $77,440 | $3,941 | 5.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 30 | 31 | $68,727 | $3,129 | 4.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $10,560 | $2,555 | 24.2% |
About Ava Anklesaria
Ava Anklesaria is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467604447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ava Anklesaria has received a total of $2,301 in payments from pharmaceutical and medical device companies, with $544.93 received in 2024. These payments were reported across 111 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,242).
As a Medicare-enrolled provider, Anklesaria has provided services to 887 Medicare beneficiaries, totaling 1,186 services with total Medicare billing of $110,450. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Bronx, NY
- Active Since 10/21/2008
- Last Updated 08/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467604447
Products in Payments
- XIFAXAN (Drug) $320.42
- SKYRIZI (Biological) $307.02
- RINVOQ (Biological) $262.07
- All products (Device) $214.00
- ZEPOSIA (Drug) $169.35
- TRULANCE (Drug) $115.49
- XELJANZ (Drug) $107.97
- Ozempic (Drug) $101.90
- STELARA (Biological) $86.60
- ZYMFENTRA (Biological) $58.61
- OMVOH (Drug) $56.72
- VEGZELMA (Biological) $55.55
- Rybelsus (Drug) $49.35
- HUMIRA (Biological) $46.11
- SUCRAID (Drug) $36.04
- DIFICID (Drug) $34.58
- IBSRELA (Drug) $27.58
- CRE (Device) $27.50
- Epclusa (Drug) $24.13
- UPTRAVI (Drug) $23.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Internal Medicine $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Internal Medicine $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Internal Medicine $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Internal Medicine $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Internal Medicine $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229
Internal Medicine $163,229